Effectiveness of probiotics against oral mucositis
- Conditions
- Breast cancer
- Registration Number
- JPRN-jRCTs061210028
- Lead Sponsor
- Kawaguchi Hiroyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
1.Age 20 years or older at the time of obtaining consent
2.Those who are scheduled to receive chemotherapy for breast cancer.
(docetaxel therapy : using docetaxel or TC therapy: using paclitaxel and carboplatin, not limited to the first treatment)
3.Those who have Grade 1 or less of oral mucositis due to other chemotherapeutic agents within the pre-observation period.
4.Those who can provide written consent for participation in this study
1.Those who have taken a probiotic preparation within the last 3 months prior to the start of the study.(General lactic acid bacteria preparations such as yogurt are excluded.)
2.Those who have had serious side effects with probiotic pre parations in the past
3.Those who develop oral mucositis due to physical irritation such as dental caries, non-conforming prosthesis
4.Any person who, while participating in this research, participates in any other clinical research using the food or research procedures being studied
5.Any other person deemed inappropriate by the principal investigator or sub-investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.